BPG is committed to discovery and dissemination of knowledge
Citation
Wu YZ, Wu M, Zheng XH, Wang BZ, Xue LY, Ding SK, Yang L, Ren JS, Tian YT, Xie YB. No long-term survival benefit with sustained-release 5-fluorouracil implants in patients with stages II and III gastric cancer. World J Gastroenterol 2022; 28(38): 5589-5601 [PMID: 36304092 DOI: 10.3748/wjg.v28.i38.5589]
Please LOGIN to submit a new comment.